Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Thymoma × envafolimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 4 Colorectal Neoplasms 2 Thymoma 1 Squamous Non-small Cell Lung Cancer 1 Sarcoma 1 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Neoplasms, Multiple Primary 1 Neoplasm Metastasis 1 NSCLC 1 Meningeal Carcinomatosis 1 Lung Neoplasms 1 HER2-positive Breast Cancer 1 Gastrointestinal Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Colonic Neoplasms 1 Chondrosarcoma 1 Carcinoma, Ovarian Epithelial 1 Biliary Tract Neoplasms 1 Advanced Pancreatic Cancer 1

Interventions

Radiotherapy 2 selinexor 1 pembrolizumab 1 isophosphamide mustard 1 epacadostat 1 envafolimab 1 Sunitinib 1 Ramucirumab 1 Radiation Dose Hypofractionation 1 Paclitaxel 1 Nivolumab 1 Leucovorin 1 Histocompatibility Testing 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Chemoradiotherapy 1 Carboplatin 1 68Ga-pentixafor 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06019468 2023-09-06

Neoadjuvant Treatment For Locally Advanced Thymic Cancer

Shanghai Pulmonary Hospital, Shanghai, China

Phase 2 Unknown

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡